Search

The article offers information on the Massachusetts Eye and Ear Infirmary (MEEI) in Boston, Massachusetts and its goal of developing residents into first-class clinicians and well-rounded academicians. According to MEEI residency program director John I. Loewenstein, MD, residents need to publish one research paper during their residency. Joan W. Miller, MD, chief of ophthalmology at MEEI, describes the culture at MEEI as one that is dedicated to teaching residents.

Announces the 26th annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) and the 14th annual meeting of the American Society of Ophthalmic Administrators (ASOA) to be held from May 20 to 24, 2000 in Boston, Massachusetts. Hall of Fame Awards; Scientific paper presentations; Course offerings.

The article focuses on the life and works of M. Judah Folkman, founder of the vascular biology program at Children's Hospital Boston, Massachusetts, who died on January 14, 2008 due to a heart attack. Folkman was born in 1933 in Cleveland, Ohio, and studied at Harvard Medical School, Boston, Massachusetts. It is stated that his work in cancer research led to breakthroughs in treating age-related macular degeneration (AMD). Comments of Folkman's colleagues regarding him have been given.

Presents an interview with James Hintlian, the lead partner for Accenture's Health & Life Sciences Supply Chain practice on the Electronic Product Code (EPC) and ePedigree industry program in Boston, Massachusetts. Discussion of the implementation of radio frequency identification systems and EPC technologies; Issues affecting the supply chains; Product authentication.

The article reports on a meeting on glaucoma diagnosis and treatment held recently in Boston, Massachusetts. The meeting highlights that the National Library of Medicine's EntrezPubMed search engine is a useful tool for quickly finding published study results and other information from the medical literature. Understanding how to evaluate this information and apply it to patient treatment is the key to practicing evidence-based medicine. It also suggests that the Early Manifest Glaucoma Trial demonstrated that glaucoma treatment lowers progression by 50 percent in representative early-to-moderate open-angle glaucoma.

Examines the effectiveness of reverse transcriptase-polymerase chain reaction (RT-PCR) on predicting survival of patients with hormone-refractory prostate cancer in Boston, Massachusetts. Mechanism of RT-PCR; Survival rate of the patient with circulating prostate cancer cells; Association between circulating cells and patient prognosis.

The article reports on the results of a study by researchers at Massachusetts Eye and Ear Infirmary in Boston, which showed that inflammation plays a role in the pathogenesis of wet age-related macular degeneration (AMD). The researchers have discovered the pathogen capable of inducing chronic infection, Chlamydia pneumoniae, in the diseased eye tissue of several patients with wet AMD.

Reports on the appointment of J. Wayne Streilein as president of the Schepens Eye Research Institute. Schepens' area of study; Shifting of focus under Streilein's leadership.

The article reports on the findings of a study conducted by Dr. Michael D. Howell, director at Beth Israel Deaconess Hospital Center in Boston, Massachusetts. It highlights the findings of study which revealed that the use of proton pump inhibitors (PPIs) increases the risk of nosocomial infection caused by Clostridium difficile. It states that patients under PPI therapy have increased the risk of C. difficile infection by 1.4 percent.

The article presents the study conducted by the researchers of Harvard Medical School regarding the use of selective cryolysis in removing adipose tissue in Boston, Massachusetts. The study administered to black Yucatan pigs aims to determine the sensitivity of the adipose tissue to cold. The scheme shows that selective cryolysis can be a promising and safe procedure and local treatment for removing excess fats.

Highlights the DTC National conference in Boston, Massachusetts. Discussion of issues related to consumer marketing; State of the pharmaceuticals business; Establishment of business partnership and industrial relationships.

Focuses on the effectiveness of tyrosinase assay technique (TTA) in detecting pigment cell defects in Boston, Massachusetts. Sensitivity of TTA in detecting active tyrosinase in a tissue sample; Comparison on the efficacy between TTA and dopa reaction; Efficiency of TTA in measuring the efficacy of sunscreens.